hcwbiologics.com (HCWB) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
HCW Biologics Inc. (HCWB) onkologiya va qarishga qarshi davolash vositalarini ishlab chiqish uchun yetakchi immunologiya mutaxassislarini birlashtirib, ularni zamonaviy laboratoriya imkoniyatlari bilan ta'minlaydi. 0.00 ko'rsatkichi aks etgan ushbu narx harakati grafigi autoimmun patologiyalarni nishonga oluvchi oqsillarga yo'naltirilgan faol R&D sa'y-harakatlariga asoslangan. Jamoaning barqarorligi sezilarli tadqiqot moliyalashtirishi, rahbariyatning nufuzi va olimlar uchun jozibador aksiyalar opsion dasturlari bilan ta'minlanadi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_HCWB_-_HCW-Biologics-Inc._-_Long-Term-Debt-to-Capital "HCWB: HCW Biologics Inc Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 30.10.2026 | 👁️GURU.Markets👁️")
HCW Biologics, Inc. (HCWB) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati HCW Biologics Inc.|HCWB - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati HCW Biologics Inc|HCWB - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati HCW Biologics Inc.|HCWB - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi HCW Biologics|Tezkor likvidlik ko‘rsatkichi hcwbiologics.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:hcwbiologics.com - HCWB
Ushbu koeffitsient uzoq muddatli majburiyatlar va kapital o'rtasidagi bog'liqlikni aks ettirib, kompaniyaning moliyaviy leveraj darajasini o'lchaydi. Investorlar uchun haddan tashqari yuqori qarz yuklamasi xatarlarini baholashda ushbu muvozanatni kuzatib borish muhimdir. Uzoq muddatli qarzning sof aktivlarga nisbati tahlili orqali qarz kapitalining biznes barqarorligiga ta'sirini aniqlash mumkin. HCW Biologics Inc. (HCWB) uchun bu tashqi pudratçilarga (CRO) yuqori bog'liqlik tufayli juda muhimdir. Bunday moliyalashtirish tuzilmasi kompaniyaning murakkab klinik sinovlarni qo'llab-quvvatlash qobiliyatini belgilaydi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Septerna Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti PVLA (Pieris Corp)|SVRA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati rigel.com|Uzoq muddatli qarzning o'z kapitaliga nisbati ANAB|Uzoq muddatli qarzning o'z kapitaliga nisbati Astria Therapeutics Inc (ATXS)|Uzoq muddatli qarzning o'z kapitaliga nisbati ENGN (enGene Bio)|RAPT (rapt.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati JBIO (Aerovate Therapeutics)|aclaristx.com - Uzoq muddatli qarzning o'z kapitaliga nisbati|Kyverna Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Tiziana Life Sciences Ltd. TLSA|Cabaletta Bio, Inc (CABA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Ventyx Biosciences, Inc (VTYX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Theratechnologies Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati AVTX|Uzoq muddatli qarzning o'z kapitaliga nisbati Eledon Pharmaceuticals, Inc. (ELDN)|AGEN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati CLYM (Climb Bio, Inc.)|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati zurabio.com|aTyr Pharma, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Adagene ADAG|IMA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Shattuck Labs|Uzoq muddatli qarzning o'z kapitaliga nisbati Equillium Inc|Connect Pharma (CNTB) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati IMUX (Immunic, Inc.)|ATRA (atarabio.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati IFRX (InflaRx)|Uzoq muddatli qarzdorlikning kapitalga nisbati X4 Pharmaceuticals Inc. (XFOR)|ACET - Uzoq muddatli qarzning o'z kapitaliga nisbati|CELU (Celularity Inc.) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|INMB: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati barinthusbio.com|Uzoq muddatli qarzning o'z kapitaliga nisbati KZR|SAB Biotherapeutics Inc. (SABS) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati AKTX|ENLV (enlivex.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati QTTB (Q32 Bio)|GOVX - Uzoq muddatli qarzning o'z kapitaliga nisbati|EDSA: Uzoq muddatli qarzning o'z kapitaliga nisbati|iBio Inc (IBIO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CARM: Uzoq muddatli qarzning kapitalga nisbati|XTLB (XTL Bio) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Bolt Biotherapeutics Inc.|Aptevo - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati AIM|ADTX (aditxt.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati GRI (GRI Bio Corp)|Uzoq muddatli qarzning kapitalga nisbati XORTX Corp XRTX|HIND - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti REVB (revbiosciences.com)|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Scinai Immunotherapeutics Ltd|CALI (CalciMedica Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Affimed Therapeutics|Uzoq muddatli qarzning o'z kapitaliga nisbati ALLK (Allakos Inc.)|HOOK (hookipapharma.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati IGMS (IGM Biosciences)|Uzoq muddatli qarzdorlikning kapitalga nisbati iTeos Therapeutics Inc (ITOS)|OCEA - Uzoq muddatli qarzning o'z kapitaliga nisbati|TC BioPharm Ltd (TCBP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Third Harmonic Bio (THRD) - Uzoq muddatli qarzning o'z kapitaliga nisbati